EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions

Eleftherios Chatzimichail, Eirini Christodoulaki, Panagiotis A G Konstas, Georgios N Tsiropoulos iD, Efstratia Amaxilati iD, Konstantin Gugleta, Zisis Gatzioufas, Georgios D Panos iD

Drug Design, Development and Therapy · 2025-04 · Volume 19 · 2519-2531

DOI: 10.2147/dddt.s515166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025-04. Verfasst von Eleftherios Chatzimichail und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital of Basel, Basel, 4031, Switzerland. Hauptthemen laut MEDLINE: Glaucoma, rho-Associated Kinases, Protein Kinase Inhibitors. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucomarho-Associated KinasesProtein Kinase InhibitorsHumansIntraocular PressureAnimalsIsoquinolinesSulfonamides

Stichwörter der Autor:innen

AR-13324K-115ROCK inhibitors in glaucomaRho-associated protein kinaseRho-kinasenetarsudilripasudil

Substanzen

rho-Associated KinasesProtein Kinase InhibitorsK-115IsoquinolinesSulfonamides

Autor:innen und Institutionen

  • Department of Ophthalmology, University Hospital of Basel, Basel, 4031, Switzerland.
  • Eye Centre of Greece, Pylaia, Thessaloniki, Greece.
  • First Department of Ophthalmology, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Division of Ophthalmology and Visual Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

ORCID-Profile: Georgios N Tsiropoulos, Efstratia Amaxilati, Georgios D Panos

Zitieren

APA

Chatzimichail, E., Christodoulaki, E., Konstas, P. A. G., Tsiropoulos, G. N., Amaxilati, E., Gugleta, K., Gatzioufas, Z., & Panos, G. D. (2025). Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions. Drug Design, Development and Therapy, Volume 19, 2519-2531. https://doi.org/10.2147/dddt.s515166

Vancouver

Chatzimichail E, Christodoulaki E, Konstas PAG, Tsiropoulos GN, Amaxilati E, Gugleta K, et al. Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions. Drug Design, Development and Therapy. 2025;Volume 19:2519-2531. doi:10.2147/dddt.s515166

BibTeX
@article{Chatzimichail2025,
  author = {Chatzimichail, Eleftherios and Christodoulaki, Eirini and Konstas, Panagiotis A G and Tsiropoulos, Georgios N and Amaxilati, Efstratia and Gugleta, Konstantin and Gatzioufas, Zisis and Panos, Georgios D},
  title = {Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {2519--2531},
  doi = {10.2147/dddt.s515166}
}
Kostenlos starten →